Cycloastragenol Inhibits Experimental Abdominal Aortic Aneurysm Progression

Cycloastragenol Inhibits Experimental Abdominal Aortic Aneurysm Progression

The pathogenesis of abdominal aortic aneurysm involves vascular inflammation and elastin degradation. <i>Astragalus</i><i>radix</i> contains cycloastragenol, which is known to be anti-inflammatory and to protect against elastin degradation. We hypothesized that cycloastrageno...

Full description

Bibliographic Details
Main Authors: Leander Gaarde Melin, Julie Husted Dall, Jes S. Lindholt, Lasse B. Steffensen, Hans Christian Beck, Sophie L. Elkrog, Pernille D. Clausen, Lars Melholt Rasmussen, Jane Stubbe
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Biomedicines
Subjects:
aortic aneurysm
pathogenesis
pharmacological therapy
experimental model
drug delivery
Online Access:https://www.mdpi.com/2227-9059/10/2/359

Internet

https://www.mdpi.com/2227-9059/10/2/359

Similar Items